Efficacy and Safety of Variable-Dose Versus Continuous-Dose Abrocitinib Treatment in Patients with Moderate-to-Severe Atopic Dermatitis: A Pooled Analysis. - Silverberg, Jonathan I.; Simpson, Eric L.; Farooqui, Saleem A.; Chan, Gary; Biswas, Pinaki; Güler, Erman (Dermatology & Therapy, 2026)